Bayer CropScience Limited (BOM: 506285)
India
· Delayed Price · Currency is INR 5,892.10
-184.85 (-3.04%)
At close: Nov 14, 2024
Bayer CropScience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 5,796 | 7,405 | 7,582 | 6,453 | 4,931 | 4,745 | Upgrade
|
| Depreciation & Amortization | 658 | 732 | 786 | 640 | 730 | 637 | Upgrade
|
| Other Amortization | 8 | 8 | 9 | 5 | 5 | 16 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12 | 24 | -5 | 6 | -64 | -79 | Upgrade
|
| Asset Writedown & Restructuring Costs | 191 | 191 | 1 | 17 | 4 | 12 | Upgrade
|
| Loss (Gain) From Sale of Investments | -180 | -148 | -135 | -94 | -103 | -7 | Upgrade
|
| Provision & Write-off of Bad Debts | 543 | 108 | 50 | 109 | 46 | 39 | Upgrade
|
| Other Operating Activities | 88 | 857 | -786 | -919 | 1,392 | 1,015 | Upgrade
|
| Change in Accounts Receivable | -213 | 129 | 313 | -2,563 | -378 | -205 | Upgrade
|
| Change in Inventory | 1,969 | 2,072 | -3,579 | -2,364 | -3,956 | 1,644 | Upgrade
|
| Change in Accounts Payable | 2,605 | -2,681 | 533 | -97 | 3,558 | -1,691 | Upgrade
|
| Change in Other Net Operating Assets | -700 | 819 | 1,324 | 962 | 702 | 533 | Upgrade
|
| Operating Cash Flow | 10,753 | 9,516 | 6,093 | 2,155 | 6,867 | 6,659 | Upgrade
|
| Operating Cash Flow Growth | 140.13% | 56.18% | 182.74% | -68.62% | 3.12% | 53.86% | Upgrade
|
| Capital Expenditures | -501 | -457 | -773 | -554 | -420 | -413 | Upgrade
|
| Sale of Property, Plant & Equipment | 51 | 63 | 47 | 81 | 108 | 134 | Upgrade
|
| Divestitures | - | - | 1,111 | 614 | - | - | Upgrade
|
| Investment in Securities | -21 | 17 | 104 | 231 | -11 | -400 | Upgrade
|
| Other Investing Activities | 505 | 381 | 344 | 270 | 390 | 390 | Upgrade
|
| Investing Cash Flow | 34 | 4 | 833 | 642 | 67 | -289 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 125 | 490 | Upgrade
|
| Total Debt Issued | - | - | - | - | 125 | 490 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -140 | -475 | Upgrade
|
| Long-Term Debt Repaid | - | -418 | -409 | -263 | -355 | -243 | Upgrade
|
| Total Debt Repaid | -409 | -418 | -409 | -263 | -495 | -718 | Upgrade
|
| Net Debt Issued (Repaid) | -409 | -418 | -409 | -263 | -370 | -228 | Upgrade
|
| Common Dividends Paid | -6,285 | -6,067 | -5,611 | -6,728 | -5,160 | -1,015 | Upgrade
|
| Other Financing Activities | -44 | -78 | -112 | -42 | -28 | -240 | Upgrade
|
| Financing Cash Flow | -6,738 | -6,563 | -6,132 | -7,033 | -5,558 | -1,483 | Upgrade
|
| Net Cash Flow | 4,049 | 2,957 | 794 | -4,236 | 1,376 | 4,887 | Upgrade
|
| Free Cash Flow | 10,252 | 9,059 | 5,320 | 1,601 | 6,447 | 6,246 | Upgrade
|
| Free Cash Flow Growth | 155.02% | 70.28% | 232.29% | -75.17% | 3.22% | 67.63% | Upgrade
|
| Free Cash Flow Margin | 19.99% | 17.75% | 10.35% | 3.38% | 15.13% | 17.30% | Upgrade
|
| Free Cash Flow Per Share | 228.12 | 201.57 | 118.37 | 35.62 | 143.45 | 138.98 | Upgrade
|
| Cash Interest Paid | 78 | 78 | 112 | 42 | 28 | 24 | Upgrade
|
| Cash Income Tax Paid | 1,321 | 1,321 | 2,395 | 2,642 | 1,625 | 1,575 | Upgrade
|
| Levered Free Cash Flow | 8,759 | 7,102 | 3,949 | 680.63 | 5,559 | 6,452 | Upgrade
|
| Unlevered Free Cash Flow | 8,857 | 7,225 | 4,089 | 754.38 | 5,628 | 6,531 | Upgrade
|
| Change in Net Working Capital | -4,368 | -1,306 | 1,227 | 4,026 | -697 | -2,152 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.